BCR and neoplasm: The signaling pathways that are activated downstream of the BCR in MZL cells have not been investigated in detail, but analysis of primary tumor samples by phospho-flow cytometry demonstrated constitutive activation of SRC family kinases, SYK, PLCγ2, and p65 NF-κB [159].